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BSE can propagate in sheep 
co‑infected or pre‑infected 
with scrapie
Angela Chong1, James D. Foster1, Wilfred Goldmann1, Lorenzo Gonzalez2, Martin Jeffrey2, 
Matthew J. O’Connor3, Keith Bishop4, Ben C. Maddison4, E. Fiona Houston1*, 
Kevin C. Gough 3* & Nora Hunter1
To understand the possible role of mixed‑prion infections in disease presentation, the current study 
reports the co‑infection of sheep with bovine spongiform encephalopathy (BSE) and scrapie. The 
bovine BSE agent was inoculated subcutaneously into sheep with ARQ/ARQ or VRQ/ARQ PRNP 
genotypes either at the same time as subcutaneous challenge with scrapie, or three months later. 
In addition, VRQ/VRQ sheep naturally infected with scrapie after being born into a scrapie‑affected 
flock were challenged subcutaneously with BSE at eight or twenty one months‑of‑age. Sheep 
were analysed by incubation period/attack rate, and western blot of brain tissue determined the 
presence of BSE or scrapie‑like  PrPSc. Serial protein misfolding cyclic amplification (sPMCA) that 
can detect very low levels of BSE in the presence of an excess of scrapie agent was also applied to 
brain and lymphoreticular tissue. For VRQ/ARQ sheep challenged with mixed infections, scrapie‑like 
incubation periods were produced, and no BSE agent was detected. However, whilst ARQ/ARQ sheep 
developed disease with BSE‑like incubation periods, some animals had a dominant scrapie western 
blot phenotype in brain, but BSE was detected in these sheep by sPMCA. In addition, VRQ/VRQ 
animals challenged with BSE after natural exposure to scrapie had scrapie‑like incubation periods and 
dominant scrapie  PrPSc in brain, but one sheep had BSE detectable by sPMCA in the brain. Overall, 
the study demonstrates for the first time that for scrapie/BSE mixed infections, VRQ/ARQ sheep 
with experimental scrapie did not propagate BSE but VRQ/VRQ sheep with natural scrapie could 
propagate low levels of BSE, and whilst BSE readily propagated in ARQ/ARQ sheep it was not always 
the dominant  PrPSc strain in brain tissue. Indeed, for several animals, a dominant scrapie biochemical 
phenotype in brain did not preclude the presence of BSE prion.
Transmissible spongiform encephalopathies (TSEs) or prion diseases are fatal neurodegenerative conditions that 
occur naturally in various mammalian species, for example sheep (scrapie), deer (chronic wasting disease, CWD) 
and humans (e.g. Creutzfeldt Jacob Disease, CJD). TSEs are protein misfolding diseases but are unusual in that 
they are also transmissible between individuals, For instance, some TSEs can be transmitted through contact with 
bodily  fluids1, via environmental  contamination2, via contaminated feed/food3 or by experimental  inoculation4, 
5. With scrapie, the infectious agent, or prion, is readily detected in excreta and  secreta6–10 and is widespread in 
the environment of such infected  animals11, 12. The prion protein (PrP) is central to the pathogenesis of TSEs 
and exists in two main isoforms.  PrPC is a normal host protein which is expressed in many cell types especially 
in brain, and misfolded  PrPSc which is so closely associated with TSE infectivity that it is believed to form part, 
or all, of the infectious  agent13. Incoming  PrPSc in an inoculum is believed to convert endogenous  PrPC into 
more  PrPSc and hence to spread and replicate.  PrPSc generated during disease progression is deposited in brain 
and lymphoid tissues and neuronal vacuolation is usually found at post mortem in infected brain. The protein 
conversion process  (PrPC to  PrPSc) can be mimicked in vitro including, in some cases, the creation of de novo 
infectivity, in a process termed serial protein misfolding cyclic amplification (sPMCA)14, 15.
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TSEs are frequently studied experimentally in mice and sheep models from which considerable information 
has been generated over many decades on the transmission properties and characteristics of multiple prion 
strains. Strains can be defined in terms of incubation period (time between infection and disease)16, 17, interac-
tion with particular host PrP (PRNP)  genotype5, pathology, immunohistochemical (IHC) detection of patterns 
of  PrPSc  distribution18 and the appearance of the extracted  PrPSc protein on western  blots19–21. Strains are more 
usually studied singly in isolation where their characteristics are reproducible and predictable and therefore 
allow the study of particular aspects of early infection, pathology and pathogenesis. However, natural scrapie 
infections in sheep are not always due to a single strain and can be the result of mixtures of  strains22, 23. Multiple 
passage in mice of isolates of natural scrapie can produce several different strains depending on the mouse lines 
used at each  passage22, 24, 25. This has been interpreted as selection, from the original sheep classical scrapie infec-
tion, of particular strains that replicate more quickly or more efficiently in specific mouse lines, both inbred and 
 transgenic22, 24, 25. Similar findings for CWD transmission in transgenic mice also suggest that deer infection 
might consist of more than one strain per  outbreak26. Direct evidence for mixed infection within single sheep 
has been reported for classical scrapie and atypical  scrapie27, 28, and the report of  PrPSc in natural sheep scrapie 
with features akin to both bovine spongiform encephalopathy (BSE) and classical scrapie could be the result of 
mixed infection or a hybrid strain  phenotype29.
Compared with the considerable literature on the biology of single TSE strain infections, much less has been 
reported on the effects of deliberately mixing strains. Because of the indirect methods used to identify strains, it 
is necessary to use two strains with easily identifiable features, for example short and long incubation periods, 
different patterns of brain vacuolation (lesion profiles) and those producing  PrPSc with distinguishable patterns 
on western blots and/or differential antibody binding. In this way it has been established that a strain with a long 
incubation period can interfere with the ability of a short incubation period strain to produce  disease30, 31. The 
strength of the interference is dependent on route of infection and precise timing but complete blockage of one 
strain by another can  occur32. These studies gave rise to the idea that the number of replication sites is finite and 
that the binding of one strain will preclude binding of a second superinfecting strain. If large enough amounts 
of the first strain are used, the replication sites were postulated to be completely occupied and the superinfecting 
strain cannot then  replicate32.
Additionally, strain interference was also demonstrated using the oral route suggesting it can occur in natu-
ral  infections33 and evidence points strongly at  PrPC being the limiting resource (replication site) for which the 
strains  compete34. Further studies in hamsters have also shown that although following some mixed infections 
all clinical disease and pathology seem to result from the faster replicating strain, more sophisticated tests  (PrPSc 
stability) suggest that the slower replicating strain is still present, perhaps at low  levels23.
Studies have shown that certain combinations of strain do not compete, and animals have the pathology 
and  PrPSc of the shorter incubation strain without delay in incubation  periods35–37. In addition, the two coin-
fecting strains can replicate independently, where an animal has the pathology of the shorter incubation strain 
without delay, but  PrPSc is a mixture of both  strains23, 36–38. Surprisingly, some animals can display a dominant 
 PrPSc phenotype of a blocking strain yet the incubation period and clinical signs indicative of the faster  strain23. 
In addition, the use of certain combinations of a non-transmissible strain with a highly pathogenic strain for 
coinfections can cause delay in the disease caused by the pathogenic strain. This suggests that either the non-
pathogenic strain can replicate to some extent or that agent replication is not required for strain  interference36. 
Overall, studies suggest that coinfections can lead to an inhibitory interference of one strain over another or 
independent replication of one or both strains.
Here, we present for the first time a study of mixed TSE infection in sheep. We used natural scrapie, SSBP/1 
experimental scrapie and cattle BSE; the latter can be distinguished from the scrapie strains by incubation 
period, IHC and western  blotting39, 40. Furthermore, a specific in vitro replication assay (sPMCA) that can detect 
BSE  PrPSc even in the presence of a large excess of scrapie  PrPSc was also  applied41, 42. Sheep of different PRNP 
genotypes underwent co-challenge with BSE and scrapie (SSBP/1) or pre-infection with scrapie (either SSBP/1 
or natural  scrapie43) followed by BSE, and incubation periods were indicative of either scrapie or BSE disease. 
For selected animals, brain was analysed using western blotting to detect the dominant  PrPSc type. Furthermore, 
brain and lymphoid tissue were analysed by a high sensitivity BSE-specific sPMCA assay. The objectives were 
to ascertain whether BSE will cause clinical disease when in competition with scrapie, and also to determine 
whether sheep displaying a scrapie phenotype in brain by conventional analysis (western blotting) could still 
harbour BSE prions.
Results
Incubation periods of sheep infected with scrapie and/or BSE. Cheviot sheep with VRQ/ARQ and 
ARQ/ARQ PRNP genotypes (referring to the three codons at positions 136, 154, 171) were injected subcutane-
ously with: SSBP/1 alone (S), BSE alone (B), SSBP/1 and BSE administered on the same day (S/B) or SSBP/1 
followed after 3 months by BSE (S + B3m).
The results of VRQ/ARQ sheep challenges are presented in Table 1 and Fig. 1. For SSBP/1 alone, all five 
inoculated sheep developed TSE clinical signs. The mean incubation period was 234 ± 41 days post injection 
(dpi). When challenged with BSE alone, only two out of six sheep developed TSE clinical signs with incubation 
periods of 1008 and 1229 dpi. Of the four sheep that did not develop clinical signs, two survived to the end of 
the study at 2001 dpi and two were culled with intercurrent disease (not TSE) at 774 and 1379 dpi. 
All VRQ/ARQ sheep challenged with both SSBP/1 and BSE developed TSE clinical signs. S/B sheep (n = 17) 
had mean incubation period 233 ± 32 dpi. In the S + B3m group (n = 17), the data is presented in two ways. 
Firstly, the incubation period dating from the SSBP/1 inoculation, and secondly dating from the BSE inocula-
tion. Mean incubation period for the whole group (n = 17) was 245 ± 42 from scrapie challenge (161 ± 42) dpi 
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from BSE challenge). Comparing these results to those of the single inocula, the mixed infection groups had 
incubation periods indistinguishable from SSBP/1 infection (p > 0.99) and significantly different from those for 
BSE only (p < 0.001).
For VRQ/ARQ animals challenged with SSBP/1 only, there appeared to be shorter incubation periods for 
sheep with PRNP codon 141 genotype LF compared to  LL141. However, numbers were low and inconsistent effects 
of this codon on incubation periods have previously been reported in similarly small cohorts of sheep challenged 
subcutaneously with SSBP/15. Indeed, with the much larger mixed infections groups, incubation period did not 
appear to be influenced by the codon at 141 (p > 0.99 and p = 0.70 within S/B and S + B3m groups, respectively).
The incubation period results for the sheep of ARQ/ARQ PRNP genotype were in general much longer than 
those of VRQ/ARQ sheep (Table 1 and Fig. 1). For SSBP/1 alone, four out of the six sheep developed TSE clinical 
signs, with a mean incubation period of 1541 ± 392 dpi. There were two survivors at the end of the study at 2002 
dpi. Although numbers are low, there was no evidence that codon 141 had any influence on incubation period 
(p = 0.89) as the four clinically positive animals included two each of  FF141 (1245 and 1763 dpi) and  LF141 (1169 
and 1987 dpi). For BSE alone, all six challenged sheep developed TSE clinical signs, with mean incubation period 
of 909 ± 289 dpi. In this case the codon 141 genotype appeared to have an influence on incubation period length 
with the  LF141 genotype having longer incubation periods (p = 0.03; Table 1, Fig. 1b).
Table 1.  Incubation periods of TSE inoculated sheep. a S: time between scrapie inoculation and culling. b B: 
time between BSE inoculation and culling. c NS: time between birth (assumed exposure to scrapie) and culling. 
d This animal had the P168L polymorphisms associated with longer incubation times for BSE. e This animal had 
the M112T polymorphisms associated with longer incubation times for BSE.
PRNP genotype
136/154/171 Challenge group Codon 141 subgroup Number challenged
Clinically positive and  PrPSc positive Clinically negative and  PrPSc negative
Number
Mean incubation period in days 
(± SD)a,b,c Number Survival times, range in days
VRQ/ARQ
SSBP/1 alone
All 5 5 234 (± 41) 0
LL 2 2 276,  280d 0
LF 3 3 204 (± 7) 0
BSE alone
All 6 2 1008, 1229 4 774–2001
LL 5 2 1008, 1229 3 774–2001
LF 1 0 1 2001
S/B
All 17 17 233 (± 32) 0
LL 6 6 232 (± 41) 0
LF 11 11 233 (± 28) 0
S + B3m
All 17 17 S: 245 (± 42)B:161 (± 42) 0
LL 6 6 S: 239 (± 43)B: 155 (± 43) 0
LF 11 11 S: 248 (± 43)B: 164 (± 43) 0
ARQ/ARQ
SSBP/1 alone
All 6 4 1541 (± 398) 2 2002, 2002
LL 0
FF 3 2 1245, 1763 1 2002
LF 3 2 1169, 1987 1 2002
BSE alone
All 6 6 909 (± 289) 0
LL 1 1 516 0
FF 2 2 678, 851 0
LF 3 3 1136 (± 159) 0
S/B
All 17 15 918 (± 195) 2 1960e, 1975
LL 0
FF 9 9 791 (± 83) 0
LF 8 6 1107 (± 153) 2 1960, 1975
S + B3m
All 17 17 S: 998 (± 206)B: 914 (± 206) 0
LL 1 1 S: 643B: 559 0
FF 8 8 S: 866 (± 79)B:782 (± 79) 0
LF 8 8 S: 1130 (± 213)B: 1046 (± 213) 0
VRQ/VRQ
NS All 6 6 NS: 793 (± 74) 0
NS + B8m All 9 9 NS: 777 (± 50) 0
NS + B21m All 9 9 NS: 803 (± 68) 0
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In ARQ/ARQ sheep (n = 18) receiving a mixed inoculation (S/B), 15 developed clinical TSE signs with mean 
incubation period 918 ± 195 dpi indicative of a BSE incubation period. Although this group included no  LL141 
sheep, there was evidence that the  FF141 homozygotes had shorter incubation periods than  LF141 heterozygotes 
(mean 791 ± 83 and mean 1107 ± 153, respectively), although a slight overlap is present between groups (Fig. 1b; 
p = 0.002). Two further  LF141 sheep remained healthy until they were culled at 1960 and 1975 dpi; one of these 
was heterozygous for the M112T PRNP polymorphism, which has previously been associated with resistance to 
 TSEs44. A further animal was culled due to intercurrent disease at 421 days was also not included in the analysis.
In the S + B3m (n = 17), all sheep developed TSE clinical signs. Mean incubation period was 998 ± 206 days 
post scrapie challenge and 914 ± 206 days post BSE challenge, suggestive of BSE pathology. Again, the  LF141 
animals had longer mean incubation periods than  LL141 and  FF141 animals (p = 0.006), but again there was 
some overlap (Fig. 1b). Across all ARQ/ARQ animals that produced a BSE like incubation period, TSE disease 
incubation period was strongly influenced by the genotype at codon 141, with heterozygote  LF141 sheep having 
extended duration to clinical disease (p < 0.001).
Comparing the results of mixed infections to those of the single inocula in ARQ/ARQ sheep, the mixed 
infection groups had incubation periods similar to BSE infection (p = 0.91 and p = 0.95 for S/B and S + B3m, 
respectively) and significantly different from those for scrapie (p < 0.001).
Incubation times of natural scrapie sheep super‑infected with BSE. Incubation time of VRQ/
VRQ natural scrapie (NS) Roslin sheep (n = 6) was 793 d ± 74 until scrapie clinical signs developed. Of those 
animals which also received an inoculation of BSE at 8 m of age (NS + B8m, n = 9) clinical TSE signs developed 
Figure 1.  Incubation periods of individual VRQ/ARQ, ARQ/ARQ and VRQ/VRQ sheep. Sheep were 
inoculated with SSBP/1 scrapie, BSE or mixtures (A,B) or were infected with natural scrapie and then 
superinfected with BSE (C). The codon 141 PRNP genotype is indicated:  LL141 (grey fill);  LF141 (black fill); 
 FF141 (no fill). Circles are clinical and pathology positive sheep, triangles are non-TSE animals. In A and B, 
lines represent SSBP/1, BSE, S/B, S + B3m dating from SSBP/1 inoculation (S), and S + B3m dating from BSE 
inoculation (B). In C, lines represent natural scrapie (NS) and NS superinfected with BSE at 8 months of age 
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and animals were culled with incubation time of 777 ± 50 days. In the group that received an inoculation of BSE 
at 21 m of age (NS + B21m, n = 9), incubation time was 803 ± 68 days. These incubation times are very similar 
to those of the control group showing no effect of the BSE super-infection (p = 0.69). Times of death following 
the BSE inoculation were 532 ± 53 days and 182 ± 68 days for NS + B8m and NS + B21m groups, respectively, 
and these times are likely to be too short to be BSE incubation periods or for the clinical signs to be the result 
of BSE rather than natural scrapie. We do not have data on subcutaneous inoculation of VRQ/VRQ sheep with 
BSE alone, however after intracerebral inoculation of VRQ/VRQ sheep with BSE, the average incubation period 
was > 1000  days5.
Differential western blot analysis of  PrPSc in brain from inoculated sheep. The determination 
of the presence of BSE or scrapie-like  PrPSc in brain was carried out by western blot analysis of proteinase K 
(PK) digested samples (Fig. 2, Supplementary Fig. S1, Table 2 for individual animals). BSE can be distinguished 
from scrapie on western blot by the slightly lower molecular weight of the unglycosylated  PrPSc band (19 kDa 
vs 20 kDa). This reflects an altered PK cleavage site resulting in reduced staining by monoclonal antibody P4 
in comparison to 6H4 in BSE samples, due to loss of the P4  epitope39. As expected, VRQ/ARQ sheep infected 
with SSBP/1 alone (n = 4) showed the typical scrapie-like  PrPSc western blot profile, whilst the two VRQ/ARQ 
sheep infected with BSE alone displayed the BSE western blot profile (n = 2). VRQ/ARQ sheep infected with S/B 
or S + B3m (n = 10 in total) all produced a scrapie-like  PrPSc pattern on western blot, in agreement with their 
incubation periods, which were as expected for SSBP/1 in this genotype. Similarly, ARQ/ARQ sheep infected 
with SSBP/1 alone (n = 2) showed scrapie-like  PrPSc whereas those infected with BSE alone (n = 6) showed typi-
cal BSE-like  PrPSc profiles. ARQ/ARQ sheep infected with S/B (n = 8) showed  PrPSc patterns that were BSE-like, 
again in accordance with the incubation period data, which was typical of ARQ/ARQ sheep infected with BSE 
rather than SSBP/1. Six out of eight ARQ/ARQ sheep infected with S + B3m, gave a BSE-like  PrPSc pattern on 
western blot. However, in two animals (Z73 and Z115) with the  LF141 genotype, western blotting of  PrPSc gave a 
scrapie-like signature.
In the natural scrapie sheep groups (n = 9), the  PrPSc profile on western blot were all indicative of scrapie, 
regardless of whether or not they were also challenged with BSE.
Figure 2.  PrPSc phenotype in sheep brain. Brain homogenates were digested with PK and analysed on western 
blots probed with 6H4 (A) or P4 (B). Representative blots are shown. Approximate molecular weight (MW) 
indicated at 30 kDa and 20 kDa. Individual sheep references (e.g. Z107 or 70 × 71 formats) are indicated. A 
relatively low MW for the unglycosylated PrP band with 6H4 staining or a relatively low P4 signal (a ratio of 
6H4/P4 signal of > 2) indicated the  PrPSc had a BSE phenotype; strong P4 staining (a ratio of 6H4/P4 signal of 2 
or less) and a relatively high MW unglycosylated band indicated a scrapie phenotype. These criteria and strain 
phenotypes are indicated. Shaded samples indicate sheep inoculated/infected with a single strain, all of these 
samples conformed to established molecular phenotypes of BSE or scrapie  PrPSc and so provided within-blot 
controls for these phenotypes. Where samples were subjected to repeat analysis, the assay gave consistent results 
(examples shown for Z107, 70 × 71 and Z13).
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Table 2.  BSE-specific sPMCA test results compared with BSE and scrapie  PrPSc determination by western 
blot analysis for individual sheep. a Animal codes are given (e.g. Z75). b SC: Scrapie. c NEG: negative for BSE 
by PMCA, –: not done, A: sample not analysed due to autolysis. d PSLN: prescapular lymph node e − 8 or − 21 
indicate superinfection with BSE was carried out at 8 or 21 months of age, respectively.
Prnp genotype Inoculation group Animal ID (codon 141 subgroup)a
Western  blotb BSE-specific  sPMCAc
Brainc Brain Spleen PSLNd
VRQ/ARQ
SSBP/1
Z75 (LF) SC NEG NEG NEG
Z94 (LF) SC NEG NEG NEG
Z26 (LF) SC – – –
Z45 (LL) SC – – –
BSE
Z48 (LL) BSE BSE NEG BSE
Z65 (LL) BSE BSE BSE BSE
S/B
Z92 (LL) SC NEG NEG NEG
Z114 (LF) SC NEG NEG NEG
S + B3m
Z66 (LF) SC NEG NEG NEG
Z146 (LL) SC NEG NEG NEG
Z161 (LF) SC NEG NEG NEG
Z172 (LF) SC NEG NEG NEG
Z121 (LF) SC – – –
Z136 (LL) SC – – –
Z49 (LL) SC – – –
Z20 (LF) SC – – –
ARQ/ARQ
SSBP/1
Z10 (LF) SC NEG NEG NEG
Z35 (FF) SC NEG NEG NEG
BSE
Z13 (FF) BSE BSE BSE BSE
Z28 (LF) BSE BSE NEG BSE
Z37 (LL) BSE BSE BSE BSE
Z43 (LF) BSE BSE BSE A
Z53 (LF) BSE BSE BSE BSE
Z58 (FF) BSE BSE BSE BSE
S/B
Z79 (FF) BSE BSE BSE BSE
Z91 (FF) BSE BSE BSE BSE
Z97 (FF) BSE BSE NEG NEG
Z113 (FF) BSE BSE BSE BSE
Z116 (FF) BSE BSE BSE BSE
Z88 (LF) BSE – – –
Z107 (LF) BSE – – –
Z63 (FF) BSE – – –
S + B3m
Z54 (FF) BSE BSE NEG NEG
Z90 (FF) BSE BSE BSE BSE
Z115 (LF) SC BSE BSE BSE
Z73 (LF) SC NEG BSE BSE
Z64 (FF) BSE – – –
Z44 (FF) BSE – – –
Z59 (LF) BSE – – –
Z139 (FF) BSE – – –
VRQ/VRQ
NS
74 × 66 (LL) SC NEG NEG NEG
75 × 17 (LL) SC NEG NEG NEG
70 × 71 (LL) SC – – –
NS +  Be
70 × 64 (LL)-21 SC NEG NEG NEG
72 × 35 (LL)-21 SC NEG NEG NEG
74 × 44 (LL)-8 SC NEG NEG NEG
75 × 09 (LL)-8 SC NEG NEG NEG
75 × 44 (LL)-8 SC BSE NEG NEG
74 × 90 (LL)-8 SC – – –
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sPMCA analysis to detect BSE in inoculated sheep. During the study, a sPMCA method became 
available that can detect very low amounts of BSE  PrPSc in a background of an excess of  scrapie41, 42. The assay 
does not detect scrapie  PrPSc. Previous reports use the method with brain tissues, here it was applied to both 
brain, spleen and prescapular lymph node (PSLN) material. Initial analysis demonstrated that the use of LRS 
tissue did not have any matrix effects on the assay and the lowest level of ovine BSE brain spike that was analysed 
(a 10,000 × dilution of a BSE infected brain seed) was detected when diluted into brain or the LRS healthy tissues 
(data not shown).
Selected samples from each challenge group or control groups were analysed by sPMCA using both LRS and 
brain tissues; each animal had also been analysed by a differentiating western blot that could define a dominant 
scrapie or BSE  PrPSc type in brain (Table 2, Fig. 3, Supplementary Fig. S2). The sPMCA assay did not detect BSE 
in any scrapie-only experimental challenge controls, as expected (4 × each of brain, spleen and PSLN samples). All 
samples from BSE-only challenged animals were positive for BSE with the exception of two spleen samples (from 
8 × brain, 8 × spleen and 7 × PSLN samples). This may indicate that the BSE agent does not accumulate consistently 
within the spleen at clinical stages of disease. For experimental mixed infections (S/B, S + B3m) in sheep with 
VRQ/ARQ genotype, the sPMCA correlated with the western blot and incubation period data, in that all sheep 
examined (n = 6) had no detectable BSE  PrPSc in brain, spleen or PSLN. For ARQ/ARQ sheep challenged with S/B 
(n = 5), BSE was detected in all brains and all but one animal had BSE present in the LRS samples analysed. The 
exception was Z97 that was negative for BSE in spleen and PSLN. In ARQ/ARQ sheep challenged with S + B3m, 
BSE was present in the brain and /or PSLN and spleen for all four animals analysed. For Z115, the sPMCA data 
showed BSE present in brain and LRS tissues and this was discordant with a dominant scrapie western blot in 
the brain. Similarly, Z73 was previously shown to have a dominant scrapie brain  PrPSc profile in western blots 
and whilst the brain was also negative for BSE by sPMCA, BSE could be detected in spleen and PSLN.
For NS infection, no BSE was found in scrapie-only controls (n = 2), as expected. In the animals superinfected 
NS + B21m (n = 2), no BSE was present in brain or LRS. When BSE superinfection was NS + B8m (n = 3), all 
samples examined were negative for BSE, except the brain sample from animal 75 × 44. The western blot profile 
for this brain indicated scrapie  PrPSc was dominant.
Immunohistochemistry analysis of tissue from sheep demonstrating a dominant scrapie 
western blot profile in brain but also propagating BSE in the LRS. Previous work has shown that 
BSE and scrapie can be distinguished on IHC by including certain antibodies (e.g. 12B2) that label intracellular 
 PrPd (intraneuronal in brain, in tingible body macrophages of lymphoid tissues) in scrapie-infected, but not 
BSE-infected  sheep40. This method was therefore applied to samples from the two animals in the S + B3m group 
that demonstrated discordant data in western blot and sPMCA, Z115 and Z73. Both demonstrated a dominant 
scrapie phenotype in brain by western blot but the presence of BSE prion in brain and/or LRS by sPMCA. Tissues 
for animal Z73 could not be reliably analysed due to autolysis. IHC data for Z115 confirmed that the dominant 
TSE type in brain was scrapie whilst that in LRS (tonsil) was BSE (Fig. 4).
Discussion
There are relatively few reports on the study of mixed prion infections. Rodent models have demonstrated that 
experimental infection with two prion strains can result in the dominance of the strain with the most favourable 
replication properties such as a shorter incubation time. In these circumstances this dominant strain can cause 
pathology with correlating  PrPSc phenotype accumulation at the end stage of  disease36, 38, 45. However, models have 
also shown that the slower replicating strain can delay or completely block the disease of the faster  strain33, 35, 46. 
Figure 3.  sPMCA amplification of BSE prions in sheep brain and LRS tissues. Following amplification of 
samples by sPMCA, PK-resistant  PrPSc was detected with either SHa31 (top panels) or P4 (lower panels). 
Representative blots are shown. Br brain, Sp spleen, Ln PSLN tissue. Scrapie (S+) and BSE (B+) brain controls 
were also analysed on each blot. Z37 and Z43 were ARQ/ARQ sheep inoculated with BSE only; Z97 was an 
ARQ/ARQ sheep inoculated with S/B; Z90, Z115 and Z73 were ARQ/ARQ sheep inoculated with S + B3m; Z94 
was a VRQ/ARQ sheep inoculated with SSBP/1 only; Z65 and Z48 were VRQ/ARQ sheep inoculated with BSE 
only; sheep 75 × 44 had natural scrapie and was superinfected, NS + B8m. Molecular weight markers (M) are 
shown at 20, 30 and 40 kDa and positions are also indicated on each blot.
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The delayed disease then usually has the clinical presentation and  PrPSc of the faster strain. Alternatively, mixed 
infections can result in independent replication of both  strains37.
This is the first study on experimentally mixed infections in sheep. There has been considerable historical 
concern that the BSE agent may have propagated in sheep and been masked by the scrapie agent. This was a 
particular concern in the UK where endemic scrapie existed and it was considered that sheep were probably 
exposed to BSE-contaminated feed during the bovine BSE epidemic (Statement by Spongiform Encephalopathy 
Advisory Committee: “Experimental transmission of BSE to sheep and risk of exposure to BSE through feed 
(10/07/1996). Archived at: https:// webar chive. natio nalar chives. gov. uk/ 20070 30809 2252/ http:// www. seac. gov. 
uk/ state ments/ state 10jul 96. htm). However, considerable surveillance has failed to detect any BSE cases in sheep 
and only two from goats, despite sheep being susceptible to bovine BSE through experimental oral  challenge47. 
This raises the questions of how coinfection of scrapie and BSE compete or co-exist within a ruminant host. To 
investigate this, we carried out mixed infection studies in sheep with scrapie and ovine BSE. The study looked 
at sheep challenged with both TSEs simultaneously and also when challenged with BSE three months after scra-
pie. In addition, sheep naturally infected with scrapie were challenged with BSE at eight and 21 months of age.
VRQ/ARQ sheep propagate SSBP/1 scrapie with a mean incubation period was 234 ± 41 days post injection 
(dpi), which compares well with previous  studies48. This disease progression is more effective and more rapid 
(approximately 5 × shorter incubation period) than BSE. Challenge with BSE alone resulted in only two out of 
six sheep developing TSE clinical signs with incubation periods of 1008 and 1229 dpi. In contrast, in a previous 
study, VRQ/ARQ  (LL141) sheep infected with BSE by the intracerebral route had average incubation periods 
of 875 ± 77 dpi and a 100% attack  rate5. Data illustrates that infection with BSE by subcutaneous inoculation is 
less efficient than intracerebral inoculation. Mixed infections of such sheep with both strains resulted in a rapid 
progression to clinical disease and only scrapie  PrPSc could be detected in brain or LRS by western blotting in 
animals that were tested, and sPMCA failed to detect low levels of BSE  PrPSc. These data indicate that the VRQ/
ARQ sheep died from scrapie infections before the BSE agent could accumulate to a detectable level and that the 
BSE agent did not compete with the scrapie agent when animals were infected with both strains. This supports 
the conclusion that challenge of sheep with BSE did not interfere with scrapie disease progression in a genotype 
where scrapie is the faster replicating strain.
The propagation of SSBP/1 and BSE in ARQ/ARQ sheep presents a different scenario, where BSE propagates 
more efficiently and slightly more rapidly (~ 1.7 × shorter incubation period) than scrapie. For SSBP/1 alone, 
four out of the six sheep developed TSE clinical signs, with a mean incubation period of 1541 ± 392 dpi, with 
Figure 4.  Discriminatory immunohistochemistry of sheep brain and tonsil from a mixed infection sheep with 
scrapie signal in brain and BSE in periphery. Sections of medulla [lateral cuneate nucleus; (A, B); × 20] and 
tonsil [(C,D); × 10) from VRQ/ARQ sheep Z115 were stained with antibody R145 in (A) and (C); or 12B2 in 
(B) and (D). Results show labelling of intraneuronal  PrPd with both R145 and 12B2 in brain (A,B), whereas in 
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two survivors at the end of the study at 2002 dpi. This prolonged incubation period is similar to a previous study 
that challenged ARQ/ARQ sheep with SSBP/1 and reported no clinical disease at 1108  days48. For BSE alone, 
all six challenged sheep developed clinical disease with mean incubation period of 909 ± 289 dpi. For challenge 
with both TSEs at the same time, the incubation periods were more reflective of BSE infection but the attack rate 
was incomplete. Western blot and sPMCA showed that the  PrPSc present in brain and LRS was BSE. Combined, 
data indicates the animals in this cohort likely all died from the BSE agent that was the dominant  PrPSc in the 
tissues analysed. For delayed challenge with BSE after scrapie inoculations, the outcomes were more complex. 
The incubation periods were relatively rapid and with high attack rates indicating BSE infections. Biochemical 
analysis of tissues showed that most sheep displayed dominant BSE  PrPSc in all tissues analysed. However, two 
sheep had a dominant scrapie  PrPSc/PrPd phenotype in brain (examined by western blot and/or IHC) despite 
displaying incubation periods most indicative of BSE infection. These animals also had BSE agent present in 
LRS tissues and/or brain when analysed by sPMCA. This data correlates with a small number of individual 
animals in a rodent model of prion superinfections where they displayed a dominant  PrPSc phenotype of the 
slower blocking strain yet the incubation period and clinical signs were indicative of the faster  strain23. There 
is no assay available that can detect very low levels of scrapie  PrPSc in the presence of high levels of BSE  PrPSc 
and so it is not known whether the ARQ/ARQ sheep with BSE pathology and a dominant BSE  PrPSc phenotype 
harboured low levels of scrapie  PrPSc.
When considering the polymorphism at position 141, this did not appear to have any influence on the 
incubation periods for VRQ/ARQ sheep where scrapie pathology was dominant. In contrast, in ARQ/ARQ 
sheep where BSE-like incubation periods were observed, the  LF141 genotype had significantly longer incubation 
periods than homozygous genotypes. A similar effect has been previously reported for BSE infections in ARQ/
ARQ  sheep49. The small number of ARQ/ARQ sheep infected with SSBP/1 only did not show any evidence that 
codon 141 influenced incubation period.
For natural scrapie infections followed by BSE challenge, all animals displayed scrapie like  PrPSc in brain by 
western blot. No amplifiable BSE  PrPSc could be detected in spleen or PSLN by sPMCA. However, one of five 
brain samples analysed by sPMCA showed the presence of BSE even though the dominant western blot signature 
was scrapie-like. Again, this demonstrates the replication of multiple prion strains within a ruminant host and 
the masking of the presence of BSE prion by a dominant scrapie pathology.
Whilst this was not an exhaustive study of ovine genotypes and their susceptibility to mixed infections, the 
study demonstrates that in sheep, a rapid TSE strain usually ‘out competes’ a slower propagating strain and 
causes the pathology/clinical disease. However, the data also shows that the dominant  PrPSc does not always cor-
relate with this pathology, for instance scrapie can be the most dominant  PrPSc in brain even though incubation 
periods would indicate a BSE disease. Furthermore, the dominant  PrPSc strain found in brain does not preclude 
the presence of another co-infecting strain. Here, of thirteen co-infected sheep that displayed a scrapie-like 
biochemical phenotype in brain by western blot analysis and were also analysed by sPMCA, three had detect-
able BSE in brain and/or LRS. This study therefore highlights that surveillance for specific TSE strains requires 
analyses of distinct tissues with a suite of biochemical tests to fully elucidate their presence or likely absence. 
This is significant as strains present at low levels within mixed infections could potentially become the dominant, 
disease-causing agent due to changes in the replication environment, for example sub-passage into a host with 
a different PRNP genotype.
Methods
Sheep inoculations. For experimental infections, Cheviot sheep were sourced from the Defra flock of New 
Zealand origin that was free of classical scrapie. The sheep genotypes were confirmed as previously  described47 
(eg VRQ/ARQ). After the project was initiated, and animal groups chosen, additional sequencing detected vari-
ation at other codons (112, 141 and 168) on the ARQ alleles encoded by the sheep. Numbers of animals with 
codon 112 or 168 variants were too small to be informative (single animals), however codon 141 variation (L 
replaced with F) was much greater, although in uneven proportions, and is presented here as a genotype at codon 
141 alone (LL, FF or LF in Tables, or e.g.  LL141 in text). The other relevant sheep PRNP allele is VRQ, which shows 
no variation at codons 112, 141 or 168.
Sheep of genotypes VRQ/ARQ and ARQ/ARQ were challenged with the well characterised scrapie brain 
pool, SSBP/148 and/or with cattle BSE, an inoculum termed BBB/2/02 made by pooling six cattle brains sup-
plied by the Animal and Plant Health Agency (APHA) and used previously in other sheep challenge  studies50. 
Animals were injected subcutaneously in the medial thigh with 10% (w/v) homogenates of SSBP/1 or BSE alone 
or together in mixed inoculations. Sheep were challenged with either SSBP/1 or BSE by injection of two separate 
1 ml doses (2 ml total dose) into each hind leg. The mixed injection groups, herein described as S/B, were each 
injected with 2 ml of a 1:1 by volume mixture of SSBP/1 and BSE homogenates in each hind leg. The separate 
injection groups, herein described as S + B3m, were first injected with 2 × 1 ml SSBP/1, and 3 months (84 days) 
later with 2 × 1 ml BSE in each hind leg. All sheep were between 789 and 878 days old at the primary challenge.
To investigate the interaction of BSE and natural scrapie, Cheviots were sourced from the Roslin Scrapie 
Flock (NPU Cheviot Flock). Natural scrapie is endemic in these sheep affecting 100% of VRQ/VRQ sheep at 
around 2 years of age. Infection is assumed to occur in these animals at or around the time of lambing but the 
timing is not known precisely. Incubation times for disease in these animals is calculated from birth. It is likely 
that by the time the sheep were exposed to BSE, natural scrapie infection would have been well established. This 
part of the study aimed to replicate more closely a realistic situation whereby a sheep incubating natural scrapie 
might become superinfected with BSE by peripheral infection. A control group of VRQ/VRQ sheep was left to 
develop natural scrapie with no additional challenge and are described as NS sheep. Additional animals were 
inoculated subcutaneously with BSE as above (2 × 1 ml of 10% BSE cattle brain homogenate into the hind limbs). 
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These animals are described as NS + B. Animals were either challenged with BSE at 8 months of age (NS + B8m; 
age at challenge was between 234 and 258 days) or were challenged at 21 months of age (NS + B21m; age at chal-
lenge was between 614 and 633 days), the latter time point is just prior to the expected development of natural 
scrapie clinical signs.
All of the animals were observed daily for clinical signs of TSE and culled humanely once such signs were 
clearly seen at agreed end-points. Any animals with intercurrent illness were treated by a veterinary surgeon and 
culled humanely if recovery was not apparent. All animals were subject to post mortem collection of brain and 
lymphoid tissues, for subsequent analysis. Times between inoculation and culling were recorded as follows. An 
incubation period was assigned when an animal had both TSE clinical signs and positive  PrPd detection by IHC 
analysis of brain. A survival time was assigned when an animal was negative for one or both of these features 
(TSE signs and  PrPd). Sections of the brainstem at the level of the obex and the thalamus from all sheep, including 
intercurrent deaths, were labelled by IHC using the monoclonal antibody BG4 (binding epitopes at 47–57 and 
89–99 in bovine PrP), in order to achieve a positive or negative confirmation of disease status (data not shown 
but outcome is implicit in the reported incubation periods).
All sheep studies were reviewed and approved by Animal Welfare and Ethical Review Committees at IAH 
Compton and the Roslin Institute and carried out in accordance with the Animals (Scientific Procedures) Act 
1986, under the authority of UK Home Office Project and Personal Licenses (and complying with the ARRIVE 
guidelines).
Statistical analysis of incubation period data was carried out using one way ANOVA followed by Tukey’s 
multiple comparison analysis when comparing incubation times between challenge groups. When comparing 
coinfection groups to BSE only challenge, the incubation times from BSE challenge were used; when compar-
ing coinfection groups to scrapie only challenge, the incubation times from scrapie challenge were used. When 
comparing incubation periods between sheep homozygote or heterozygote for codon 141, an unpaired Student’s 
T test was used.
Detection of BSE or scrapie  PrPSc by western blotting. Selected samples were subjected to  PrPSc 
analysis by PK digestion and western blot analysis as previously  described39, 40. Samples were run on 16% (w/v) 
Tris–glycine gels (Invitrogen, Paisley, UK) and immunoblotted onto polyvinylidene difluoride (PVDF) mem-
branes. For detection of sheep  PrPSc, two monoclonal antibodies were used: 6H4 (epitope 144–152 in human 
PrP, Prionics, Schlieren, Switzerland, 2 mg/ml, diluted 1:5000), and P4 (epitope 93–99 in ovine PrP; R-Biopharm, 
Darmstadt, Germany, 1 mg/ml, diluted 1:2500). The "visualisation" process used a chemiluminescence substrate 
(Roche, Lewes, UK) and Lumi-film (Roche). For re-probing a membrane with a second antibody, the 6H4 anti-
body was removed using Restore (Thermo Fisher Scientific, Loughborough, UK) and then the membrane was 
re-probed with the P4 antibody. Each blot was imaged at 3 different exposure times (30 s, 3 min and 10 min) 
to allow visualisation of the unglycosylated band. The molecular weight of this band was determined by com-
parison to the MW markers and was assigned as relatively low or high with a difference of ~ 2 kDa. Densitom-
etry analysis (using Image J) of blots allowed identification of the ratio of  PrPSc signals after probing with each 
antibody, a ratio of 6H4/P4 signal greater than 2 indicated BSE, analysis criteria are as previously  described39. 
Samples were defined as BSE or scrapie when they consistently met both MW and relative P4 reactivity criteria. 
However, some ovine BSE samples could not be resolved to determine the MW of the unglycosylated band (due 
to very low levels of this form of  PrPSc), in these cases the definition of BSE was confirmed by the P4 reactivity 
criteria alone.
Serial PMCA to detect BSE  PrPSc. Selected sheep tissues were examined using sPMCA optimised for the 
specific detection of BSE as previously  described41. This technique scores samples as positive or negative for BSE 
and does not detect scrapie. In summary, tissue (100–150 mg) was homogenised in lysis buffer (PBS containing 
0.5% (w/v) sodium deoxycholate and 0.5% (v/v) NP40 to give a final 10% (w/v) tissue) using a mini beadbeater 
set at 4800 rpm for 60 s (brain and spleen) or 180 s (PSLN). Homogenised samples were aliquoted and frozen 
at − 80 °C. sPMCA amplification was carried out for 5 rounds in total using alternating AHQ/AHQ and VRQ/
VRQ sheep brain substrates for each round. For amplifications, two different sPMCA sonicator horns were each 
used to analyse a replicate of the same sample. A sample was noted as being BSE positive if either replicate pro-
duced  PrPSc with a BSE western blot phenotype. During the sPMCA, samples were diluted 1:3 every 24 h with 
the substrate, as previously  described41. An equal number of test samples and scrapie only (negative control) 
samples were amplified on each sPMCA run. No negative controls produced any  PrPSc signal (data not shown).
Following sPMCA, samples were digested with 50 µg/ml PK at 37 °C for 1 h in the presence of 0.5% (w/v) SDS. 
An equivalent to 5 µl of the original PMCA reaction was then subjected to SDS PAGE using a 12% (w/v) NuPAGE 
electrophoresis system with MOPs buffer. The separated proteins were electroblotted to PVDF membrane and 
blocked with 3% (w/v) milk protein overnight. Duplicate blots were probed with the monoclonal antibody SHa31 
(epitope 145–151 in hamster PrP) or P4. Densitometry analysis of blots probed with SHa31 allowed identification 
of samples that produced a  PrPSc signal above the background produced with control scrapie samples. Samples 
were scored positive for BSE when producing a SHa31 signal above background and a ratio of their SHa31/P4 
signal greater than 2.9, analysis criteria are as previously  described41, 42. We have previously demonstrated the 
limit of detection of BSE by sPMCA in the presence of scrapie-infected  brain41. The assay gave 100% sensitivity 
at 1/50 dilution of BSE in scrapie, falling to 90% and 80% sensitivity at 1/225 and 1/500 dilutions, respectively. 
Here, a demonstration of the assay limit of detection was again performed, to further evaluate any effects of 
the spleen and PSLN matrix with respect to the amplification of BSE. These experiments were carried out twice 
using two different sPMCA sonicators. Due to delays in the availability of spleen tissue from TSE-free sheep, 
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these experiments were carried out in a background of healthy ovine brain and PSLN samples and the spleens 
of tg338 mice (mice expressing ovine VRQ PrP)51.
Detection of BSE or scrapie  PrPd by immunohistochemistry. The IHC methods do not result in 
detection of  PrPC but as no PK is used in the process, the PrP protein detected by IHC is referred to here as 
disease-associated PrP  (PrPd)40. The term  PrPSc is reserved for the protein detected in PK treated samples.
Brain and lymphoid tissues were analysed using a method that discriminates between BSE and scrapie and has 
been described in detail several times  previously18, 40. When antibodies that recognise specific epitopes within the 
N terminus of PrP are used, epitopes to the sequence 93–99 of the PrP protein are preserved in SSBP/1 but lost 
in  BSE40. Labelling was with R145 (epitope 221–232 in bovine PrP) and the N-terminal discriminatory antibody 
12B2 (epitope 93–97 in bovine PrP).
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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